Ziptel Ltd

ZIP Details
Overseas R&D claim approval: Ziptel Ltd.’s (ASX: ZIP) stock price soared 21.1% on April 18, 2017 and has risen 40.7% in last five days (as at April 13, 2017). The group’s overseas R&D claim has been approved as it received a certificate for overseas finding under section 28C of the Industry Research and Development Act 1986 for FY15/16. By virtue of this, ZIP will now bank a R&D Program tax rebate worth $632,643 in due course.Zip recently updated that the group appointed an external IT contractor to operate and manage the Zipt and AussieSim platforms, and is progressing well on the delivery of a SaaS enterprise solution using the patent protected ZiFi Intellectual Property.
 

ZiFi Target Markets (Source: Company Reports)
 
With short term revenue opportunities identified and efforts to deliver cost savings with monthly expenditure to fall to circa $30,000, the prospects look positive. We give a “Speculative Buy” on the stock at the current price of $ 0.046
 

ZIP Daily Chart (Source: Thomson Reuters) 

LatAm Autos Ltd

LAA Details
Expecting to break even in 2H 2018: LatAm Autos Ltd (ASX: LAA) reinstated to quotation on April 18, 2017 and the stock plunged 21.9%. The stock price has fallen more than 50% in six months as at January 30, 2017. The group had announced that they are progressing well in terms of unlocking car purchasing value chain and have fast tracked to break even in 2H 2018 at the back of the convertible notes issue (fully underwritten A$10 m). LAA has prioritised to monetise its Mexico, Ecuador and Peru business units and will be reducing expenditure across Argentina and Panama units. The group’s operational results from the MotorCredit and CarSync product launches have been encouraging.
 

Financial Outlook (Source: Company Reports)
 
The group could not lodge its Financial Report for the full 2016-year accounting by the reporting deadline of March 31, 2017 and has now come with the same in the month of April. We believe that LAA needs to demonstrate on its claimed mettle before being considered an investment opportunity. We give an “Expensive” recommendation at the current price of $ 0.125
 

LAA Daily Chart (Source: Thomson Reuters) 

Opthea Ltd

OPT Details
Capital raising to expand clinical development: Opthea Ltd (ASX: OPT) witnessed a stock price plunge of 2.9% on April 18, 2017 post a 52.3% rise in last six months (as at April 13, 2017). Recently, the group has obtained positive results from its Phase 1/2A clinical trial of OPT-302, for wet age-related macular degeneration (wet AMD). Particularly, the trial has been able to achieve the primary safety endpoint with OPT-302 at all dose levels either alone or in combination with Lucentis® in 51 patients with wet AMD. OPT had also launched an entitlement offer and institutional placement to raise $45 million at $0.93 per share. The group had mentioned to use the proceeds from the offer and placement for expanding the clinical development of OPT-302 as a therapy for eye disease. Although the stock has fallen 14.5% in last five days, we believe the same is still “Expensive” at the current price of $ 0.98
 

OPT Daily Chart (Source: Thomson Reuters) 

Lepidico Ltd

LPD Details
Extension of takeover proposal: Lepidico Ltd (ASX: LPD) stock price surged 43.8% in last three months (as at April 13, 2017) at the back of drilling updates and off-market takeover proposal from Lithium Australia (ASX: LIT). LIT recently announced about extending the offer period to May 05, 2017. LPD had earlier announced about commencement of drilling at Separation Rapids Lithium Project near Kenora, under a non-binding letter of intent with Avalon.Considering the prospects and the extension of the offer by LIT, we give a “Hold” recommendation at the current price of $ 0.014
 

LPD Daily Chart (Source: Thomson Reuters) 

Catapult Group International Ltd

CAT Details
Unveiling efforts for venturing into prosumer market: Catapult Group International Ltd (ASX: CAT) has released an upgraded PLAYERTEK platform, representing a major upgrade to its prosumer offering. The launch delivers complete wearable hardware and software analytics solution to the target market. The group is also set to have a formal launch of full prosumer offering in FY18. CAT has signed a number of deals lately, and one such deal is with Welsh Rugby Union. The stock has fallen about 23% in last three months (as at April 13, 2017). We give a “Speculative Buy” at the current price of $ 2.06
 

CAT Daily Chart (Source: Thomson Reuters)

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.